INSMED INC: interest expense
Interest expense for INSMED INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All INSMED INC financial histories
What this measure means
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
Exact concept: us-gaap:InterestExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2009-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 83,795,000 | USD | 2026-02-19 | 10-K · 0001104506-26-000009 |
| 2024-01-01 | 2024-12-31 | 84,913,000 | USD | 2026-02-19 | 10-K · 0001104506-26-000009 |
| 2023-01-01 | 2023-12-31 | 81,694,000 | USD | 2026-02-19 | 10-K · 0001104506-26-000009 |
| 2022-01-01 | 2022-12-31 | 26,446,000 | USD | 2025-02-20 | 10-K · 0001104506-25-000009 |
| 2021-01-01 | 2021-12-31 | 40,473,000 | USD | 2024-02-22 | 10-K · 0001104506-24-000008 |
| 2020-01-01 | 2020-12-31 | 29,564,000 | USD | 2023-02-23 | 10-K · 0001104506-23-000009 |
| 2019-01-01 | 2019-12-31 | 27,705,000 | USD | 2022-02-17 | 10-K · 0001104506-22-000008 |
| 2018-01-01 | 2018-12-31 | 25,472,000 | USD | 2021-02-25 | 10-K · 0001104506-21-000005 |
| 2017-01-01 | 2017-12-31 | 5,925,000 | USD | 2020-02-25 | 10-K · 0001104506-20-000007 |
| 2016-01-01 | 2016-12-31 | 3,498,000 | USD | 2019-02-22 | 10-K · 0001104506-19-000009 |
| 2015-01-01 | 2015-12-31 | 2,889,000 | USD | 2018-02-23 | 10-K · 0001104506-18-000002 |
| 2014-01-01 | 2014-12-31 | 2,415,000 | USD | 2017-02-23 | 10-K · 0001047469-17-000856 |
| 2013-01-01 | 2013-12-31 | 2,412,000 | USD | 2016-02-25 | 10-K · 0001047469-16-010395 |
| 2012-01-01 | 2012-12-31 | 763,000 | USD | 2015-02-27 | 10-K · 0001047469-15-001346 |
| 2011-01-01 | 2011-12-31 | 10,000 | USD | 2014-03-06 | 10-K · 0001047469-14-001864 |
| 2010-01-01 | 2010-12-31 | 109,000 | USD | 2013-03-18 | 10-K · 0001140361-13-012797 |
| 2009-01-01 | 2009-12-31 | 781,000 | USD | 2012-03-13 | 10-K · 0001140361-12-015075 |
Related financial histories
- INSMED INC: total assets
- INSMED INC: total liabilities
- INSMED INC: stockholders equity
- INSMED INC: cash and cash equivalents
- INSMED INC: net income or loss
- INSMED INC: operating cash flow
- INSMED INC: capital expenditure payments
- INSMED INC: revenue
- INSMED INC: contract revenue excluding tax
- INSMED INC: financing cash flow
- INSMED INC: investing cash flow
- INSMED INC: retained earnings or deficit
- INSMED INC: basic weighted-average shares
- INSMED INC: diluted weighted-average shares
- INSMED INC: basic earnings per share
- INSMED INC: diluted earnings per share
- INSMED INC: income tax expense or benefit
- INSMED INC: net property, plant and equipment
- INSMED INC: share-based compensation expense
- INSMED INC: operating income or loss
- INSMED INC: current assets
- INSMED INC: current liabilities
- INSMED INC: current accounts payable
- INSMED INC: goodwill carrying amount
- INSMED INC: net finite-lived intangible assets
- INSMED INC: net current accounts receivable
- INSMED INC: operating expenses
- INSMED INC: net inventory
- INSMED INC: gross profit
- INSMED INC: selling, general and administrative expense
- INSMED INC: research and development expense
Inspect the source
- Entity
- INSMED INC / CIK 0001104506
- Captured
- 2026-09-20T05:23:21.034Z
- SEC response SHA-256
22b8a34fc320451b3699d8330d59e6b2a073b8e2a90625f1c4fddaf0d3c93f47
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001104506.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))